Answers are grounded in this paper and cite their sources.
Identifies bioactive triterpenoids in Bauhinia variegata, suggesting therapeutic potential.
ABSTRACTThe identification of bioactive secondary metabolites is crucial for thepharmacological validation of medicinal plants. In this study, an Agilent7890A/5975C GC-MS system equipped with a DB-5MS column was employed toprofile Bauhinia variegata Linn. bark extract. The oven program ranged from 60 °Cto 300 °C, and compounds were identified via the NIST 4.0 library. Chromatographicanalysis resolved 21 distinct phytoconstituents. The major component was identifiedas 9,19-Cyclolanost-24-en-3-ol (12.29%), followed by significant concentrations ofpentacyclic triterpenoids, including alpha-amyrin (6.85%) and beta-amyrin (1.86%).The method effectively separated isomeric triterpenes and late-eluting sterols likegamma-sitosterol (3.29%). The results demonstrate a diverse chemical profile rich inanti-inflammatory markers, providing a standardized chemical baseline for futuretherapeutic investigations.
No takes yet. Share an insight, caveat, or question.
Abraham Theodore Rajaselwin E, Dr. C.Rubina Reichal, Dr.Sonia George (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: